INKT · Company research

MiNK Therapeutics, Inc. Common Stock (INKT): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

19records availableHealthcare

Stock News & Events data

Database-backed records only

19 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Trading Systems Reacting to (INKT) Volatility - Stock Traders DailyTrading Systems Reacting to (INKT) Volatility Stock Traders DailyView source ↗Stock Traders DailyOct 17, 2026neutral00.6
MiNK Therapeutics (INKT) CEO sells 6,938 shares solely to cover taxes owed upon vesting. - Stock TitanMiNK Therapeutics (INKT) CEO sells 6,938 shares solely to cover taxes owed upon vesting. Stock TitanView source ↗Stock TitanOct 14, 2026neutral00.6
CEO lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting. - Stock TitanCEO lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting. Stock TitanView source ↗Stock TitanOct 13, 2026neutral00.6
MiNK Therapeutics (INKT) Edges Higher as Shares Hold Above Key Support - Institutional Buy Signals - siam.inMiNK Therapeutics (INKT) Edges Higher as Shares Hold Above Key Support - Institutional Buy Signals siam.inView source ↗siam.inOct 12, 2026neutral00.6
Understanding Momentum Shifts in (INKT) - Stock Traders DailyUnderstanding Momentum Shifts in (INKT) Stock Traders DailyView source ↗Stock Traders DailyOct 7, 2026neutral00.6
MiNK Therapeutics (INKT) Slips 2.28% to $12.44 as Shares Drift Toward Lower Support - Value Area Low - https://www.siam.in/MiNK Therapeutics (INKT) Slips 2.28% to $12.44 as Shares Drift Toward Lower Support - Value Area Low https://www.siam.in/View source ↗https://www.siam.in/Oct 4, 2026neutral00.6
A cell therapy enabled killing of immunotherapy-resistant colon cancer cells in a lab model - Stock TitanA cell therapy enabled killing of immunotherapy-resistant colon cancer cells in a lab model Stock TitanView source ↗Stock TitanOct 2, 2026neutral00.6
MiNK Therapeutics to Report Second Quarter 2026 Financial Results and Provide Corporate Update on agenT-797 Clinical Progress | INKT Stock News - Quiver QuantitativeMiNK Therapeutics to Report Second Quarter 2026 Financial Results and Provide Corporate Update on agenT-797 Clinical Progress | INKT Stock News Quiver QuantitativeView source ↗Quiver QuantitativeAug 6, 2026neutral00.6
Companies Like MiNK Therapeutics (NASDAQ:INKT) Are In A Position To Invest In Growth - Simply Wall StreetCompanies Like MiNK Therapeutics (NASDAQ:INKT) Are In A Position To Invest In Growth Simply Wall StreetView source ↗Simply Wall StreetAug 6, 2026neutral00.6
What date does MiNK Therapeutics, Inc.'s (INKT) report Earnings - Earnings Calendar & Announcement - Zacks Investment ResearchWhat date does MiNK Therapeutics, Inc.'s (INKT) report Earnings - Earnings Calendar & Announcement Zacks Investment ResearchView source ↗Zacks Investment ResearchJul 16, 2026neutral00.6
Here's Why You Should Add INKT Stock to Your Portfolio Now - TradingViewHere's Why You Should Add INKT Stock to Your Portfolio Now TradingViewView source ↗TradingViewJul 16, 2026neutral00.6
INKT Forecast — Price Target — Prediction for 2027 - TradingViewINKT Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Why is Mink Therapeutics stock surging today? - Investing.comWhy is Mink Therapeutics stock surging today? Investing.comView source ↗Investing.comMay 28, 2026neutral00.6
We're Not Very Worried About MiNK Therapeutics' (NASDAQ:INKT) Cash Burn Rate - Yahoo FinanceWe're Not Very Worried About MiNK Therapeutics' (NASDAQ:INKT) Cash Burn Rate Yahoo FinanceView source ↗Yahoo FinanceMay 18, 2026neutral00.6
MiNK Therapeutics Inc (INKT) Q1 2026 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo FinanceMiNK Therapeutics Inc (INKT) Q1 2026 Earnings Call Highlights: Strategic Advances and Financial ... Yahoo FinanceView source ↗Yahoo FinanceMay 15, 2026neutral00.6
Why Did INKT Stock Jump 30% Today? - StocktwitsWhy Did INKT Stock Jump 30% Today? StocktwitsView source ↗StocktwitsMar 10, 2026neutral00.6
Why Did MiNK Therapeutics (INKT) Stock Jump 50% Premarket Today? - TokenistWhy Did MiNK Therapeutics (INKT) Stock Jump 50% Premarket Today? TokenistView source ↗TokenistMar 10, 2026neutral00.6
MiNK Therapeutics Stock Gains Amid New Market Developments - StocksToTradeMiNK Therapeutics Stock Gains Amid New Market Developments StocksToTradeView source ↗StocksToTradeMar 10, 2026neutral00.6
Key Patent Dispute Hits INKT’s Financials - timothysykes.comKey Patent Dispute Hits INKT’s Financials timothysykes.comView source ↗timothysykes.comMar 10, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.